The COVID-19 risk assessment could assist with the priority / order of the delivery of any future vaccination. Do you know how long it would take to manufacture 7.6 billion doses even when / if a vaccination is discovered!
Also, the risk assessment could be used to determine who is at a low risk and therefore, may not need the vaccination.
My understanding is, the assessment is also beneficial to understand if someone tests positive, what level of care they may require given their genetic disposition. This would determine if they can ride it out in quarantine, or whether they are likely to need hospitalisation. These are the words from their announcement "..... differentiated COVID-19 patients who required hospitalization from those who did not."
What if they packaged their tests like: Female: Breast Cancer Assessment plus Colorectal Cancer Assessment plus Type-2 Diabetes plus COVID-19 Assessment, etc Male: Colorectal Cancer Assessment plus Type-2 Diabetes plus COVID-19 Assessment, etc
Now is there value? GTG has hundreds of millions of dollars of Intellectual Property.
GTG Price at posting:
0.7¢ Sentiment: None Disclosure: Held
